Pain Control in Renal Colic

Renal Colic Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00646061
• Other study ID #: B-0705/045-005
• Status: Completed
• Phase: Phase 1
• First received: March 25, 2008
• Last updated: September 20, 2009
• Start date: November 2007
• Est. completion date: December 2008

Study information

• Verified date: September 2009
• Source: Seoul National University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

Renal colic is very common in emergency department patients. Our aim of this study is which combination of drug is more effective in renal colic.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years to 45 Years

Eligibility

Inclusion Criteria:

• adult, clinical suspicion of renal colic

Exclusion Criteria:

• under 15

• do not consent

• contraindication of morphine, ketorolac, or buscopan

• previously pain controlled

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Colic
• Renal Colic

Intervention

Drug:
• buscopan

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Bundang Hospital	Seongnam-si	Kyeongi-do

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pain control			No